Skip to content
★ Sign in to follow
NB

Nicholas Borys

Executive
Total declarations
10
Company
1
▲ Purchases (6 ops.)
€31k
▼ Sales (0 ops.)
—

Latest filing published 04 Feb 2016 for Imunon, Inc..

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
6
Positive at T+90
50%
Median T+90
+23.8%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 22 Sept 2010 · 5892 days ago · €3,507
    +9.2%
    Entry US$37,755.58 · Close at T+365 US$41,210.34
  • Filed 21 Nov 2008 · 6562 days ago · €808
    +48.6%
    Entry US$27,144.54 · Close at T+365 US$40,346.65

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Nicholas Borys: trading record in brief

This profile gathers the share dealings of Nicholas Borys in Imunon, Inc. We count 10 filings; the first trade dates from 18 June 2008 and the latest from 2 February 2016.

On the market, this insider has only ever bought: 6 purchases, €31k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants.

The median purchase comes to €5,493. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was +23.8%. These figures describe past trades and do not predict future prices.

The latest filing, published on 4 February 2016, reports a share grant in Imunon, Inc. The clock since the last published purchase (12 December 2011) now reads 5,446 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Nicholas Borys

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ◆
    CMOExecutivesImunon, Inc.
    0SEC
    12,000 sharesCelsion Corporation Common StockSEC:0001437749-16-024795:0
  • ▲
    CMOExecutivesImunon, Inc.
    10,000 USD0SEC
    5,000 shares@ US$2.00Celsion Corporation Common StockSEC:0000749647-11-000160:0
    Canonical exit: 11 Mar 2012 (T+90)
  • ●
    CMOExecutivesImunon, Inc.
    6,000 USD0SEC
    2,500 shares@ US$2.40Celsion Corporation Common StockSEC:0000749647-11-000036:0
  • ▲
    Chief Medical OfficerExecutivesImunon, Inc.
    4,697 USD0SEC
    1,550 shares@ US$3.03Celsion Corporation Common StockSEC:0000749647-10-000048:0
    Canonical exit: 21 Dec 2010 (T+90)
  • ▲
    Chief Medical OfficerExecutivesImunon, Inc.
    304 USD0SEC
    100 shares@ US$3.04Celsion Corporation Common StockSEC:0000749647-10-000048:1
    Canonical exit: 21 Dec 2010 (T+90)
  • ◆
    Chief Medical OfficerExecutivesImunon, Inc.
    22,159 USD0SEC
    7,537 shares@ US$2.94Common Stock (Bonus Grant)SEC:0000749647-10-000012:0
  • ◆
    VP & Chief Medical OfficerExecutivesImunon, Inc.
    13,600 USD0SEC
    5,000 shares@ US$2.72Common StockSEC:0001179110-09-002310:0
  • ▲
    VP & Chief Medical OfficerExecutivesImunon, Inc.
    1,010 USD0SEC
    404 shares@ US$2.50Common StockSEC:0001179110-08-019792:0
    Canonical exit: 17 Feb 2009 (T+90)
  • ▲
    VP & Chief Medical OfficerExecutivesImunon, Inc.
    13,990 USD0SEC
    5,596 shares@ US$2.50Common StockSEC:0001179110-08-019792:1
    Canonical exit: 18 Feb 2009 (T+90)
  • ▲
    VP & Chief Medical OfficerExecutivesImunon, Inc.
    12,300 USD0SEC
    3,000 shares@ US$4.10Common StockSEC:0001179110-08-012420:0
    Canonical exit: 16 Sept 2008 (T+90)

10 of 10 declarations